Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?

E-ISSN： 1600-0609|94|5|424-430

ISSN： 0902-4441

Source： EUROPEAN JOURNAL OF HAEMATOLOGY, Vol.94, Iss.5, 2015-05, pp. : 424-430

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Modern Treatment Options for Elderly Patients with Multiple Myeloma

Oncology Research and Treatment, Vol. 31, Iss. 6, 2008-05 ,pp. : 335-342

Karger

Access to resources Recommend Favorite

Treatment of Patients with Multiple Myeloma: An Overview of Systematic Reviews

Acta Haematologica, Vol. 125, Iss. 1-2, 2010-12 ,pp. : 8-22

Karger

Access to resources Recommend Favorite

Tolerability of Dose Escalation of Ibandronate in Patients with Multiple Myeloma and End-Stage Renal Disease: A Case Series

Oncology Research and Treatment, Vol. 32, Iss. 8-9, 2009-07 ,pp. : 482-486

Karger

Access to resources Recommend Favorite

Effects of Age on Responses to Treatment and Survival of Patients with Multiple Myeloma

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 31, Iss. 5, 1983-05 ,pp. : 272-277

John Wiley & Sons Inc

Access to resources Recommend Favorite

Unusual Discordant Responses in Two Multiple Myeloma Patients during Bortezomib Treatment

Oncology Research and Treatment, Vol. 31, Iss. 1-2, 2008-01 ,pp. : 45-47

Karger

Access to resources Recommend Favorite